Sign up
Log in
Jim Cramer Calls Cameco A Good Company, Recommends Buying This Financial Stock
Share
Listen to the news

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Apollo Global Management (NYSE:APO).

Apollo, on Oct. 6, announced that its managed funds agreed to acquire Eagle Creek Renewable Energy, one of the largest U.S. hydroelectric power platforms.

National Fuel Gas Company (NYSE:NFG) has “consistency,” Cramer said.

National Fuel Gas will release its fourth quarter and full year fiscal 2025 earnings results on Wednesday, Nov. 5, after the closing bell.

When asked about Main Street Capital Corporation (NYSE:MAIN), Cramer put it plainly: “We're not going there.”

Truist Securities analyst Mark Hughes, on Oct. 15, maintained a Hold rating on Main Street Capital and lowered the price target from $64 to $60.

Cramer said Cameco Corporation (NYSE:CCJ) is a good company and recommended owning that stock.

CLSA analyst Max Hopkins initiated coverage of Cameco on Sept. 9 with an Outperform rating and a $102 price target.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is a “spec,” Cramer said.

Vanda Pharmaceuticals will release results for the third quarter on Wednesday, Oct. 29, after the market closes.

Price Action:

  • Apollo Global shares rose 1.6% to settle at $125.00 on Friday.
  • National Fuel Gas shares fell 0.5% to close at $81.68.
  • Main Street Capital shares slipped 0.3% to settle at $57.45 on Friday.
  • Cameco shares gained 2.1% to close at $88.13.
  • Vanda Pharmaceuticals shares gained 0.2% to close at $5.50 on Friday.

Read Next:

Image: Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.